past
decad
develop
human
mous
model
gener
applic
biomed
research
greatli
acceler
translat
outcom
obtain
basic
research
potenti
diagnost
therapeut
strategi
clinic
chapter
fi
rstli
present
overview
histori
current
progress
divers
human
mous
model
focu
equip
reconstitut
human
immun
system
updat
advanc
establish
human
immun
system
mice
applic
studi
develop
human
immun
system
pathogenesi
multipl
human
immunerel
diseas
intens
review
shortcom
perspect
potent
tool
discuss
well
valuabl
bridg
across
gap
bench
work
clinic
trial
progress
human
mous
model
undoubtedli
continu
play
indispens
role
wide
area
biomed
research
past
centuri
applic
rodent
anim
model
especi
divers
geneengin
mous
model
provid
indispens
platform
numer
valuabl
inform
advanc
experiment
medicin
biolog
research
howev
gap
speci
still
challeng
obstacl
translat
result
rodent
human
great
advanc
technolog
molecular
biolog
gene
modifi
cation
attempt
establish
human
mous
model
made
leap
sinc
nowaday
wide
varieti
human
mous
model
gener
appli
nearli
fi
eld
biomed
research
chapter
briefl
review
histori
classifi
cation
human
mous
model
summar
current
situat
recent
advanc
applic
biomed
research
especi
research
immunerel
diseas
gener
human
mice
compos
three
main
class
human
geneexpress
transgen
mice
human
genetransgen
mice
modifi
ed
gene
knockin
replac
technolog
express
one
human
specifi
c
gene
human
mice
carri
human
tissu
liver
human
liver
mice
murin
hepatocyt
complet
partli
replac
infus
humanorigin
hepatocyt
human
mice
equip
function
human
immun
system
human
immun
system
mice
establish
immunodefi
cient
mice
transplant
human
immun
organ
cell
reconstitut
human
immun
system
mice
thu
refer
special
human
mice
follow
section
briefl
review
histori
current
advanc
human
genetransgen
mice
human
liver
mice
focu
human
immun
system
mice
human
genetransgen
mice
closer
gene
engin
mice
rather
human
mice
although
express
human
gene
protein
transgen
mice
provid
platform
studi
vivo
role
specifi
c
human
gene
molecul
valu
data
limit
translat
medicin
due
lack
human
microenviron
signal
network
mice
wide
use
human
genetransgen
mice
human
leukocyt
antigen
hla
transgen
mice
hlaexpress
transgen
mice
repres
use
tool
studi
vivo
tcrrestrict
immun
respons
thu
adopt
studi
immunerel
diseas
fi
rst
year
centuri
exampl
mice
use
induc
cellrestrict
type
diabet
experiment
autoimmun
enceph
eae
mice
appli
establish
cellmedi
eae
system
lupu
erythematosu
sle
rheumatoid
arthriti
ra
model
recent
respect
role
eae
autoimmun
diabet
also
studi
transgen
mice
meanwhil
transgen
mice
distinct
hla
subtyp
express
favor
studi
hlarel
suscept
specifi
c
diseas
eae
experiment
autoimmun
uveiti
arthriti
allerg
bronchopulmonari
aspergillosislik
pulmonari
respons
celiac
diseas
although
applic
hlatransgen
mice
reduc
due
simplifi
cation
diseas
special
immun
respons
combin
hlatransgen
technolog
reconstitut
human
immun
system
immunodefi
cient
mice
reassign
vital
biomed
research
discuss
next
section
block
lack
optim
anim
model
prehuman
mice
time
side
chen
et
al
tri
stabil
function
cryopreserv
human
hepatocyt
immun
compet
mice
novel
system
call
human
ectop
artifi
cial
liver
heal
involv
juxtacrin
paracrin
signal
polymer
scaffold
claim
mice
transplant
heal
exhibit
persist
normal
liver
function
week
thu
provid
window
drugrel
investig
howev
effi
caci
valu
human
liver
mice
develop
drug
still
debat
due
propos
side
effect
ongo
liver
injuri
caus
transgen
infl
uenc
normal
metabol
mediat
exogen
treatment
apart
potenti
applic
human
liver
mice
immunerel
research
also
deserv
explor
liver
also
repres
critic
compon
human
immun
system
develop
human
immun
system
mice
could
divid
three
phase
correspond
establish
prkdc
scid
protein
kinas
dna
activ
catalyt
polypeptid
sever
combin
immunodefi
cienci
mutat
mice
develop
nod
nonobes
diabet
scid
mice
gener
immunodefi
cient
mice
homozyg
mutat
il
interleukin
receptor
chain
locu
breakthrough
mention
previous
signifi
cantli
improv
engraft
human
immun
cell
pluripot
stem
cell
stood
mileston
way
real
human
mice
engraft
multipl
human
immun
compon
mice
surpass
convent
humangen
knockin
break
limit
viewpoint
studi
specifi
c
molecul
isol
environ
uniqu
advantag
human
immun
system
mice
favor
gener
applic
immunerel
studi
open
window
research
observ
interact
among
human
immun
cell
vivo
follow
content
focu
characterist
applic
mous
model
simpli
refer
human
mice
otherwis
specifi
ed
current
mice
establish
nodscid
recombin
activ
gene
balbc
background
wide
use
strain
reconstitut
human
immun
system
vivo
recent
use
bone
marrow
liver
thymu
blt
cotransplant
lavend
et
al
engraft
high
level
multilineag
hematopoiesi
organ
lymphoid
tissu
tripleknockout
mice
human
mice
sustain
human
cell
tissu
engraft
long
week
posttransplant
without
develop
chronic
graftversushost
diseas
gvhd
thu
repres
new
advanc
establish
human
mice
reconstitut
function
immun
system
key
evalu
success
establish
human
mice
graft
use
reconstitut
human
immun
system
includ
stem
cell
blt
peripher
blood
cell
accord
specifi
c
object
gener
stem
cell
blt
transplant
exhibit
advantag
establish
stabl
multilineag
hematopoiet
cell
might
need
addit
treatment
improv
develop
specifi
c
cell
subpopul
contrari
human
mice
establish
peripher
blood
cell
provid
readi
platform
studi
function
matur
immun
cell
length
window
appropri
research
still
limit
chronic
gvhd
ongo
reduc
engraft
maxim
potenti
human
mous
model
progress
made
recent
firstli
pretreat
geneengin
pluripot
stem
cell
exhibit
satisfactori
effect
improv
engraft
immun
cell
secondli
human
growth
factor
cytokin
signal
regulatori
protein
alpha
sirpa
express
immunodefi
cient
mice
demonstr
superior
engraft
specifi
c
immun
cell
subpopul
well
follow
paragraph
briefl
review
current
statu
reconstitut
specifi
c
immun
cell
subpopul
human
mice
lymphocyt
import
compon
immun
system
thu
draw
major
attent
although
human
peripher
blood
mononuclear
cell
pbmc
transplant
led
rapid
reconstitut
human
lymphocyt
human
mice
found
initi
activ
induct
antibodi
product
human
cell
lymphocyt
enter
unrespons
statu
due
loss
human
profession
antigenpres
cell
apc
could
revers
adopt
transfer
human
apc
activ
organresid
myeloid
dendrit
cell
dc
poli
c
treat
meanwhil
stem
celltranspl
human
mice
display
diversifi
ed
cell
repertoir
gap
hla
murin
major
histocompat
complex
mhc
molecul
prohibit
induct
effi
cient
cellmedi
primari
immun
respons
vivo
overcom
problem
hlaexpress
immunodefi
cient
mice
gener
effi
caci
confi
rmed
anoth
concern
origin
immunocompet
human
mice
support
util
applic
surrog
model
transplant
reject
autoimmun
might
caus
unwant
immun
respons
murin
tissu
antigen
well
distinct
cell
companion
reconstitut
function
b
lymphocyt
gener
poor
human
mice
need
improv
futur
although
primari
repertoir
princip
unalt
differ
mous
human
stromal
environ
abil
produc
antigenspecifi
c
antibodi
partli
develop
describ
previous
reconstitut
myeloid
cell
guarante
immun
system
intact
also
determin
develop
function
adapt
innat
lymphocyt
unfortun
monocyt
myeloid
cell
usual
exhibit
immatur
phenotyp
impair
function
human
mice
could
partli
rescu
human
coloni
stimul
factor
csf
howev
improv
surviv
differenti
even
migrat
resid
still
urgent
requir
besid
leukocyt
blood
compon
also
play
import
role
immun
respons
regul
recent
hu
et
al
establish
full
reconstitut
human
platelet
human
mice
deplet
murin
macrophag
repres
interest
attempt
construct
human
circul
mice
summari
optim
human
mous
model
still
way
advanc
molecular
biolog
cellular
biolog
system
biolog
defi
nite
bring
new
era
develop
use
tool
applic
human
mice
cover
nearli
fi
eld
biomed
research
concentr
immunerel
studi
especi
aim
mechan
translat
potenti
immun
regul
suppress
also
briefl
summar
benefi
ts
brought
potent
model
tumor
infecti
diseas
vaccin
studi
lo
earli
lineag
progenitor
etp
pret
cell
liver
human
mice
intrahepat
inject
stem
cell
establish
wonder
platform
investig
human
cell
develop
howev
joo
et
al
found
human
cell
educ
murin
mhc
mice
without
human
thymu
differ
normal
human
cell
mark
higher
express
promyelocyt
leukemia
zinc
fi
gure
protein
plzf
regardless
similar
develop
stage
correspondingli
danner
et
al
gener
mice
demonstr
critic
role
hla
class
ii
molecul
develop
function
cell
infus
hladrmatch
human
hematopoiet
stem
cell
meanwhil
role
notch
signal
develop
human
cell
evalu
human
hematopoiet
stem
celltranspl
mice
moreov
use
human
stem
cell
factor
granulocytemacrophag
colonystimul
factor
gmcsf
mice
billerbeck
et
al
found
increas
accumul
human
cell
blood
spleen
bone
marrow
liver
importantli
cell
exhibit
potent
suppress
capabl
cell
prolifer
made
signifi
cant
contribut
studi
human
regulatori
cell
treg
develop
vivo
describ
previous
develop
human
b
cell
human
mice
rel
weak
compar
cell
choi
et
al
evalu
effi
caci
busulfan
chemotherapeut
agent
claim
could
effi
cientli
improv
reconstitut
human
specifi
c
antibodi
produc
b
cell
cell
macrophag
even
dc
cord
blood
cell
less
toxic
effect
hand
kim
et
al
found
cotransplant
fetal
bone
tissu
fetal
thymu
could
facilit
develop
reconstitut
human
b
cell
fetal
liverderiv
cell
togeth
cell
besid
adapt
lymphocyt
like
b
cell
innat
lymphocyt
developmentrel
factor
also
illustr
human
mous
model
earli
huntington
di
santo
made
period
review
applic
human
mice
research
nk
cell
develop
pek
et
al
confi
rmed
crucial
role
nk
cell
develop
bone
marrow
liver
human
mous
model
believ
studi
develop
innat
lymphocyt
nkt
cell
innatelik
cell
ilt
report
near
futur
myeloid
cell
gener
regard
fragil
diffi
cult
surviv
strang
environ
made
attract
subtl
improv
reconstitut
sensit
cell
addit
human
origin
cytokin
gmcsf
gener
accept
effi
cient
way
improv
dc
matur
similarli
effect
macrophag
colonystimul
factor
mcsf
fmsrelat
tyrosin
kinas
flt
ligand
promot
develop
macrophag
dc
also
confi
rmed
human
mous
model
respect
moreov
develop
megakaryocyt
replic
use
index
dengu
virusinfect
human
mous
model
recent
also
support
multilineag
hematopoiet
cell
develop
human
mice
final
transplant
human
stem
cell
bone
marrow
patient
bone
marrow
failur
syndrom
human
mice
provid
invalu
tool
evalu
novel
genetarget
therapi
clinic
trial
summari
reconstitut
divers
human
immun
cell
popul
pluripot
progenitor
immunodefici
mice
becom
potent
platform
investig
develop
human
immun
system
next
question
creat
human
environ
mice
human
cell
advanc
studi
autoimmun
diseas
human
mice
especi
cellmedi
diseas
alway
correl
develop
hlatransgen
technolog
bachmaier
et
al
gener
doubleknockout
mice
transgen
human
specifi
calli
reconstitut
human
arm
mice
establish
dilat
cardiomyopathi
model
one
earliest
attempt
appli
human
mous
model
studi
autoimmun
diseas
use
similar
strategi
eme
et
al
establish
ra
model
combin
transgen
mice
stimul
rarel
human
autogen
protein
howev
lack
human
immun
system
reconstitut
model
constrain
repres
whole
map
occur
autoimmun
diseas
side
shultz
et
al
establish
model
mice
cotranspl
human
stem
cell
islet
cell
importantli
group
point
potenti
hlatransgen
immunodefi
cient
mice
optim
model
provid
interest
preliminari
data
soon
infl
ammatori
arthriti
type
diabet
model
establish
hlatransgen
human
mice
david
schultz
group
respect
mention
previous
cellmedi
immun
respons
gener
incomplet
human
mice
establish
convent
immunodefi
cient
mice
usual
led
insignifi
cant
clinic
symptom
thu
limit
applic
model
involv
hla
improv
effi
caci
immun
respons
also
provid
platform
studi
relationship
hla
subtyp
specifi
c
diseas
suscept
nevertheless
complex
individu
hla
phenotyp
healthi
donor
patient
still
remain
biggest
challeng
rebuild
physiopatholog
process
rel
limit
hlaexpress
human
mice
due
rel
weak
reconstitut
human
b
cell
human
mice
establish
b
cell
antibodi
mediat
autoimmun
diseas
seem
diffi
cult
cellmedi
autoimmun
diseas
kerekov
et
al
rebuilt
clinic
pathogenesi
human
mice
cell
transfer
sle
patient
evalu
potenti
b
celltarget
therapi
chimer
molecul
contain
monoclon
antibodi
human
inhibitori
complement
receptor
type
coupl
decapeptid
mimic
dna
antigen
anoth
group
led
duffi
eld
recapitul
system
vascul
human
mice
treat
igg
isol
patient
improv
reconstitut
multipl
compon
human
immun
system
human
mice
predict
induct
divers
human
b
cellmedi
autoimmun
diseas
vivo
access
soon
applic
human
mice
model
transplantationrel
diseas
aris
earli
birth
human
mice
process
tortuou
till
due
chronic
exogen
reject
ongo
decreas
immun
cell
three
studi
investig
plant
solid
graft
immunodefi
cient
mice
reconstitut
human
immun
system
induc
reject
infus
matur
human
cell
howev
longterm
outcom
model
still
clear
order
mimic
clinic
situat
human
stem
cell
appli
establish
human
mice
use
strategi
three
independ
group
report
allogen
islet
transplant
xenogen
islet
reject
xenogen
skin
reject
model
unfortun
insuffi
cient
develop
immun
cell
popul
human
mice
still
stay
obstacl
even
led
failur
reject
solv
problem
group
tri
develop
matur
human
immun
system
human
mice
transplant
human
peripher
blood
cell
group
report
novel
human
allogen
gvhd
model
establish
human
mice
reconstitut
human
pbmc
model
reproduc
typic
clinic
process
acut
gvhd
occur
allogen
bone
marrow
transplant
without
appar
interrupt
exogen
reactiv
use
model
evalu
protect
effect
human
treg
induc
ex
vivo
allogen
b
cell
found
human
treg
could
inhibit
gvhd
induc
longterm
toler
without
compromis
gener
immun
graftversustumor
gvt
activ
potent
regulatori
activ
treg
mainli
mediat
express
cytotox
lymphocyt
antigen
ctla
cell
surfac
alloantigenspecifi
citi
abil
induc
longterm
toler
favor
clinic
applic
importantli
strategi
might
reduc
clinic
depend
limit
hlamatch
donor
larg
improv
surviv
chanc
million
patient
wait
bone
marrow
transplant
human
mous
model
undoubtedli
bring
new
hope
transplant
research
also
need
keep
mind
lot
question
still
wait
answer
way
emphas
brehm
shultz
key
success
human
mous
model
includ
avail
immunodefi
cient
mous
strain
choic
tissu
transplant
specifi
c
human
immun
cell
popul
graft
besid
autoimmun
diseas
transplantationrel
diseas
human
mice
model
also
use
studi
infl
ammatori
diseas
hammad
et
al
compar
allerg
infl
ammat
lung
human
mice
reconstitut
pbmc
induc
infl
ammatori
reaction
dc
home
dust
mite
hdm
allerg
patient
healthi
donor
inject
intratrach
mice
repeat
expos
aerosol
hdm
contrast
secret
induc
mice
receiv
normal
dc
inject
dc
patient
induc
product
accompani
increas
ige
product
repres
characterist
respons
lymphadenopathi
infl
ammatori
sequela
human
mous
model
addit
immunopatholog
studi
human
mous
model
also
appli
studi
underli
mechan
injuri
repair
plate
retrovir
vectormodifi
ed
human
skin
nude
mice
ad
human
keratinocyt
growth
factor
kgf
artifi
cial
wound
skin
reepitheli
signifi
cantli
acceler
although
model
could
describ
real
human
mice
human
immun
system
involv
attempt
initi
innov
applic
human
mice
compar
satisfactori
reconstitut
circul
blood
cell
success
reconstitut
mucosa
immun
human
mice
still
absent
till
mucosa
especi
respiratori
digest
tract
surfac
play
indispens
role
protect
immun
regul
howev
resid
exchang
immun
compon
locu
still
diffi
cult
rebuild
anim
model
physiolog
dynam
remain
larg
unknown
occurr
human
mous
model
provid
perfect
platform
evalu
immunotherapi
tumor
earliest
attempt
induc
antitumor
immun
respons
human
mice
focus
gener
specifi
c
antibodi
outcom
vari
due
unstabl
human
model
new
centuri
research
start
pay
attent
develop
complet
tumorigen
especi
metastasi
process
relationship
stromal
cell
immunocompet
human
mice
made
signifi
cant
advanc
multipl
fi
eld
like
human
prostat
cancer
mixedlineag
leukemia
base
progress
novel
immunotherapi
strategi
evalu
human
mous
model
inhibitori
receptor
iglik
transcript
ilt
deplet
blockad
melanoma
nk
cellmedi
cytotox
human
breast
cancer
recent
group
report
novel
applic
pamidron
phosphoantigen
gener
use
treat
osteoporosi
treat
epsteinbarr
viru
ebv
induc
b
cell
lymphoprolif
diseas
human
mous
model
reconstitut
human
pbmc
new
applic
old
drug
mediat
expand
activ
human
cell
small
cell
popul
human
lymphocyt
might
inspir
explor
current
avail
resourc
importantli
establish
donorand
tissuespecifi
c
human
mous
tumor
model
undoubtedli
play
indispens
role
develop
individu
therapi
futur
develop
human
mice
repres
mileston
histori
human
immunodefi
cienci
viru
hiv
studi
new
gener
human
mice
improv
understand
transmiss
latenc
pathogenesi
hiv
also
provid
unpreced
platform
antivir
studi
besid
explor
effi
cient
virusspecifi
c
neutral
antibodi
convent
antiretrovir
antimicrobi
therapi
model
effi
caci
vector
immunoprophylaxi
treatment
prevent
hiv
transmiss
evalu
well
meanwhil
crucial
role
hivspecifi
c
cell
plasmacytoid
dc
pdc
replic
viru
activ
immun
respons
potenti
target
therapi
also
investig
novel
immunotherapi
assay
perform
human
mous
model
includ
blockad
program
cell
death
pd
receptor
engin
hivresist
cell
shorthairpin
rna
shrna
express
hematopoiet
stemprogenitor
cell
inhibit
hiv
replic
chimera
contain
rna
aptam
high
bind
affi
niti
hiv
envelop
protein
viru
neutral
properti
small
interf
rna
sirna
trigger
sequencespecifi
c
degrad
hiv
rna
moreov
preliminari
studi
mechan
underli
viral
control
hlab
elit
control
suppressor
es
complet
human
blt
mice
demonstr
elit
suppressor
capabl
control
due
possess
uniqu
host
factor
rather
infect
defect
viru
vivo
nowaday
could
even
make
indepth
studi
cell
dynam
hivinfect
human
mice
model
help
intravit
microscopi
therefor
countabl
futur
molecular
biolog
bring
surpris
effort
gene
therapi
hiv
except
applic
hivrel
studi
human
mous
model
also
brought
spannew
opportun
human
infecti
diseas
especi
bloodborn
pathogencaus
diseas
dengu
viru
infect
ebv
infect
hcmv
infect
htlv
infect
malaria
parasit
infect
hand
human
mous
model
leishmaniasi
salmonella
typhi
infect
herpesviru
infect
mycobacteria
infect
group
b
streptococcu
gb
infect
establish
effort
fi
lack
suitabl
anim
model
humanspecifi
c
pathogencaus
diseas
push
forward
correl
investig
develop
prevent
treatment
although
technolog
obstacl
like
replic
natur
infect
transmiss
rout
still
need
resolv
group
use
pbmctransplant
human
mous
model
evalu
novel
therapeut
strategi
target
host
rather
viru
treat
infl
uenza
viru
infect
demonstr
aminobisphosphon
control
infl
uenza
diseas
boost
human
cell
immun
benefi
cial
effect
activ
virus
vari
subtyp
virul
nevertheless
differ
characterist
molecul
tissu
organ
human
mice
might
impair
effi
cienci
pathogen
infect
initi
specifi
c
immun
respons
lassn
et
al
increas
suscept
mice
human
coronaviru
cross
aminopeptidas
n
apn
receptor
human
coronaviru
hcov
transgen
mice
signal
transduc
activ
transcript
stat
null
mice
work
togeth
hlaand
human
cytokinesgrowth
factortransgen
technolog
provid
success
exampl
futur
studi
human
infecti
agent
human
mice
next
stage
improv
versatil
variabl
human
immun
system
human
mous
model
applic
genemodifi
ed
pathogen
defi
nite
enhanc
translat
effi
cienci
model
usag
human
mice
develop
vaccin
target
human
diseas
includ
ebv
dengu
viru
infl
uenza
viru
sever
acut
respiratori
syndrom
sar
corona
viru
carcinoembryon
antigen
cea
obtain
outstand
achiev
past
decad
introduct
hla
transgen
immunodefi
cient
mice
acceler
advanc
fi
eld
improv
immun
cell
popul
reconstitut
novel
vaccin
protocol
carri
human
mice
compar
convent
mice
nonhuman
primat
model
human
mice
exhibit
great
advantag
translat
potenti
reproduct
capac
data
repeat
econom
ethic
concern
increas
applic
divers
human
mice
model
biomed
research
past
two
decad
significantli
improv
understand
human
physiolog
patholog
especi
immunolog
process
system
cellular
molecular
level
acceler
develop
current
translat
medicin
signifi
cantli
nevertheless
sever
major
caveat
develop
remain
dealt
includ
complet
replac
murin
mhc
diversifi
ed
hla
molecul
effi
cient
methodolog
express
correspond
growth
factor
cytokin
specifi
c
time
organ
prolong
mainten
human
engraft
promot
develop
myeloid
cell
increas
rel
weak
quantiti
qualiti
immun
cell
limit
develop
lymph
node
interorgan
traffi
c
immun
cell
reconstitut
red
blood
cell
granulocyt
anoth
word
import
issu
fi
nd
conveni
costeffect
way
construct
appropri
humanlik
microenviron
includ
physic
structur
intercellular
contact
molecular
signal
transfer
human
mice
forese
knowledg
exchang
age
big
data
bring
even
bright
futur
advanc
tool
ever
